로딩 중…
지수 로딩 중…
Vera Therapeutics, Inc.
VERA· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$35.09+0.23%
2026-06-18
Price Chart
Vera Therapeutics, Inc.+67.73%
Financials
No data
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $2.52B |
| Revenue | $0.00 |
| Net Income | $-369M |
| Total Assets | $622M |
| Net Assets | $500M |
| Value | |
| P/B | 5.04x |
| FCF Yield | -11.66% |
| Profitability | |
| ROE | -73.84% |
| ROA | -59.34% |
| Financial Health | |
| Debt Ratio | 24.42% |
| Total Debt | $75M |
| FCF | $-294M |
| Cash | $114M |
| Current Ratio | 13.64x |
| Performance | |
| 1Y Return | 67.73% |
| 1M Return | 5.53% |
| From 52W High | -37.40% |
| 1Y MDD | -43.85% |
| Trading | |
| Volume | 1,188,113 shares |
| Trading Value | $42M |
| Per Share | |
| EPS | $-4.66 |
| BPS | $9.41 |